Of note, 2 of the patients had IDH1-mutant tumors that would now be classified as astrocytoma, IDH-mutant, WHO grade 4, not as GBM, based on the WHO 2021 classification of tumors of the CNS.23 This evidence concerns the gene IDH1 and central nervous system neoplasm.